المشهد
How the method of birth influences a baby’s gut microbiome
Cyclosporiasis Outbreak Spreading in the US with Unknown Source of Infection
Revealed for the First Time: Heart Surgery for Egyptian Football Legend Hossam Hassan Due to the Pharaohs
Digital Genetic Twins: How Artificial Intelligence Predicts Your Illness Before It Happens
How to properly store olive oil to prevent it from spoiling faster than you think
المصدر: المشهد
10 Hrsجاهز للتشغيل
جاهز للتشغيل
Oxford University has launched its first clinical trials for a vaccine targeting the Bundibugyo strain of the Ebola virus, aiming to accelerate the development of a vaccine to combat the outbreak in Congo and Uganda. The trial involves 50 volunteers and the primary phase focuses on assessing the safety of the vaccine and the immune response it elicits, with completion expected in the coming weeks following regulatory approvals. Approximately 620,000 doses of the vaccine have been produced and stored in collaboration with the Serum Institute of India to support efforts to control the epidemic.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading